I'd expect better than 20% Rev growth at this stage considering the R&D, Sales and Capex spend, which is $70m+ in total. The issue will be whether they plan to continue at this level.
The cash-debt situation is worse than that because they have a $35m payment to make on acquisitions in current liabilities.
- Forums
- ASX - By Stock
- ELO
- Ann: FY21 Results Investor Presentation
Ann: FY21 Results Investor Presentation, page-9
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)